United States: IRS Informally Rules Disgorgement Payments Under FDA Consent Decree May Be Deductible

Last Updated: June 8 2015
Article by Douglas W. Charnas and Brian J. Malkin

In Internal Revenue Service Field Attorney Advice released May 22, 2015 (FAA 20152103F), the IRS Office of Chief Counsel expressed its informal view that the evidence suggests that the amount the taxpayer paid the United States as an equitable disgorgement of profits under a consent decree with the Food and Drug Administration (FDA) was not a non-deductible payment in the nature of a fine or penalty. The FAA falls short of stating that the payment is deductible, however; it states only that the evidence does not suggest it was a fine or penalty that would be precluded from being deducted.

The taxpayer developed and manufactured certain drugs. FDA found alleged violations at the taxpayer's drug manufacturing operation. FDA and the taxpayer agreed to the terms of a consent decree ordered by the U.S. District Court. The consent decree included: (1) detailed injunctive provisions concerning the taxpayer's manufacturing practices; (2) the taxpayer's agreement to pay equitable disgorgement of profits to the United States Treasury for the period during which the alleged violations occurred; and (3) the taxpayer's agreement to pay certain potential liquidated damages, certain potential amounts of equitable disgorgement, and certain potential future costs of FDA and the United States relating to ongoing enforcement of the terms of the consent decree.

The FAA notes that the consent decree provided that "[t]he parties acknowledge that the payment(s) under this Decree are not a fine, penalty, forfeiture, or payment in lieu thereof." It appears that the taxpayer made none of the potential payments identified in item (3) of the immediately preceding paragraph. The FAA also notes that an FDA contact informed the IRS "that FDA views disgorgement as an equitable remedy, not intended as punitive, intended to be a deterrent for other FDA-regulated companies, but not compensatory."

Section 162(f) of the Internal Revenue Code (IRC) provides that no deduction shall be allowed under IRC § 162(a) for any fine or similar penalty paid to a government for the violation of any law. Compensatory damages paid to a government are not a fine or penalty. In evaluating the characterization of a payment for purposes of IRC § 162(f), the courts look to the origin and character of the liability giving rise to the payment, according to the FAA.

The claims against the taxpayer in the FAA arose from claimed violations of §§ 331(a) and (k) of the federal Food, Drug, and Cosmetic Act (FD&C Act). The claimed violations are enforceable by injunction under § 332(a), by criminal fines and penalties under § 333(a), and by seizure of goods under § 334. Disgorgement is not specifically authorized by the FD&C Act, but the FAA notes that § 332 has been interpreted broadly to invoke the court's full equity jurisdiction, including the power to order disgorgement.

After reviewing the purposes of the statutory provisions, the FAA states that the remedy in equity (the disgorgement) takes on the purposes of the statutory origin, which includes both enforcement and compensation. Because of this, the FAA states that the intent of the parties must be examined to determine the goal the disgorgement payment was meant to further.

The FAA notes that the consent decree states that the parties acknowledge that the payment was not a fine, penalty, forfeiture or payment in lieu thereof. It goes on to state, however, that, while this language may be clear on its face, it is ambiguous because there is no evidence that it was intended to address the tax consequences of payments made under the consent decree.

The FAA states that disgorgement, in general, has a deterrent purpose. It goes on to say, however, that it was explained to the IRS that FDA does not view disgorgement as compensatory or punitive, but that it is intended to be a deterrent for other FDA-regulated companies. FDA's intent is, therefore, ambiguous noting that, while disgorgement is generally viewed as a deterrent measure, "the FDA has denied a punitive intent in this case."

Given these ambiguities, and noting that no single factor is dispositive, the FAA concludes that "the facts and circumstances taken as a whole do not indicate that the amount the Taxpayer paid as equitable disgorgement under the consent decree was a fine or similar penalty for purposes of § 162(f) ... When [the language in the consent decree stating that the disgorgement payment is not a fine, penalty, forfeiture, or similar payment in lieu thereof is] viewed in conjunction with the FDA contact's statement that the disgorgement was not meant to be punitive, and the FDA's decision not to bring a claim under the other, more clearly penal provision of § 333 of the FDCA, the facts indicate that the FDA did not intend to punish the Taxpayer. On balance, the evidence suggests that disgorgement payment was not a non-deductible fine or penalty for purposes of § 162(f)."

The FAA's conclusion is not surprising under the facts. What is notable, however, is that the IRS felt compelled to examine the issue notwithstanding the clear statement in the consent decree that the parties acknowledge that the disgorgement payment is not a fine or penalty. Had the consent decree specifically stated that the equitable disgorgement payment was not a fine or penalty for federal income tax purposes, it appears that the IRS would not have found it necessary to examine the intent of the parties. The take away from the FAA is that any settlement agreement should specifically state that the parties do not intend the payment to be a fine or penalty for all purposes, including federal income tax purposes.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions